As observed in tumors from melanoma cells sensitive to BRAF inhibitor, CRO15 induced a strong increase in LC3, active caspase 3 and TUNEL staining compared to tumor sections from control or PLX4032 (Supplemental Fig. 5B). This evidence concerns the gene MAP1LC3A and melanoma.